Pardes Biosciences, Inc.
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 …
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Pardes Biosciences, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Nuvation Bio Inc. | FMP | High | United States | New York | |
| Instil Bio, Inc. | FMP | High | United States | Dallas | |
| Shattuck Labs, Inc. | FMP | High | United States | Austin | |
| NextCure, Inc. | FMP | High | United States | Beltsville | |
| Neoleukin Therapeutics, Inc. | FMP | High | United States | Seattle | |
| Ovid Therapeutics Inc. | FMP | High | United States | New York | |
| Champions Oncology, Inc. | FMP | High | United States | Hackensack | |
| Assembly Biosciences, Inc. | FMP | High | United States | South San Francisco | |
| CytomX Therapeutics, Inc. | FMP | High | United States | South San Francisco | |
| Century Therapeutics, Inc. | FMP | High | United States | Philadelphia | |
| Eliem Therapeutics, Inc. | FMP | High | United States | Redmond |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |